Cytos Biotechnology - ClinicalTrials

Clinical

Trials

Home
Contact
Directions
Glossary
Site Map
Disclaimer

Cytos

Press Releases

Cytos

Facts & Figures

Cytos Biotechnology AG
Wagistrasse 25
Postfach
8952 Schlieren
Switzerland
T +41 44 733 47 47
F +41 44 733 47 40
e-mail contact

Please find in the table below information on ongoing and completed clinical trials for Cytos Biotechnology's lead Immunodrug™ candidates. Cytos Biotechnology also publishes clinical trial information on the publicly accessible website www.clinicaltrials.gov.

Immunodrug™	Indication	Clinical trials (phase)	More information	Partner
NIC002	Nicotine addiction	II (ongoing) II (completed) I (completed)	Fact Sheet Press Release PLoS one European Journal of Immunology
CYT006-AngQb	Hypertension	II (study 02 completed) II (study 03 completed) I/IIa (completed)	Fact Sheet Press Release Press Release The Lancet
CYT003-QbG10	Allergic rhinoconjunctivitis	IIb (completed) II (completed) IIa (completed) IIa (completed) IIa pilot (completed) I (completed)	Fact Sheet Press Release Press Release Press Release Press Release Press Release Press Release
CYT003-QbG10	Allergic asthma	II (completed)	Press Release
CYT004-MelQbG10	Malignant melanoma	IIa (ongoing) IIa (completed)	Results expected late 2009 Press Release
CAD106	Alzheimer's disease	IIa (ongoing) I (completed)	conducted by Novartis; excerpt Q2 report 2008 ICAD2008
CYT013-IL1bQb	Type II diabetes	I/IIa (ongoing)	Press Release